Hysron
Hysron Brand names, Hysron Analogs
- Amen
- Aragest
- Aragest 5
- Asconale
- Clinofem
- Clinovir
- Colirest
- Crinone
- Curretab
- Cycrin
- DMPA
- Depo-Clinovir
- Depo-Prodasone
- Depo-Progestin
- Depo-Promone
- Depo-Provera
- Depo-Subq Provera 104
- Depomedroxyprogesterone acetate
- Depot-Medroxyprogesterone acetate
- Farlutal
- Farlutin
- G-Farlutal
- Gestapuran
- Hematrol
- Hydroxymethylprogesterone
- Hysron
- Indivina
- Lunelle
- Lutopolar
- Lutoral
- MAP
- MPA
- Med-Pro
- Medroprogesterone Acetate
- Medrossiprogesterone [Dcit]
- Medroxiprogesterona [Inn-Spanish]
- Medroxiprogesteronum
- Medroxyprogesteron
- Medroxyprogesteron acetate
- Medroxyprogesterone acetate
- Medroxyprogesterone Base
- Medroxyprogesteronum [Inn-Latin]
- Meprate
- Metigestrona
- MPA Gyn 5
- Nadigest
- Nidaxin
- Novo-Medrone
- Oragest
- Perlutex
- Perlutex Leo
- Prempro/Premphase
- Prodasone
- Progestalfa
- Progestasert
- Progesterone
- Progeston
- Progevera
- Prometrium
- Provera
- Proverone
- Ralovera
- Repromap
- Repromix
- Sirprogen
- Sodelut G
- Veramix
Hysron Brand Names Mixture
- Lunelle (Medroxyprogesterone + Estradiol)
Hysron Chemical_Formula
C22H32O3
Hysron RX_link
http://www.rxlist.com/cgi/generic/medrox.htm
Hysron fda sheet
Hysron msds (material safety sheet)
Hysron Synthesis Reference
P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)
Hysron Molecular Weight
344.488 g/mol
Hysron Melting Point
220 - 223.5 oC
Hysron H2O Solubility
22.2mg/L
Hysron State
Solid
Hysron LogP
3.606
Hysron Dosage Forms
Tablets; Depo injection
Hysron Indication
Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.
Hysron Pharmacology
Medroxyprogesterone is a synthetic progestin more potent than progesterone.
Hysron Absorption
Rapidly absorbed from GI tract
Hysron side effects and Toxicity
Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.
Hysron Patient Information
Hysron Organisms Affected
Humans and other mammals
